Concepedia

Improving efficiency and sensitivity: European Research Initiative in CLL (ERIC) update on the international harmonised approach for flow cytometric residual disease monitoring in CLL

Andy C. Rawstron, Sebastian Böttcher, Rémi Letestu, Neus Villamor, Claudia Fazi, H. Kartsios, Ruth M. de Tute, Jane Shingles, Matthias Ritgen, Carol Moreno,

Leukemia · 2012 · 205 citations · 27 references

DOI

Concepts

References

27

Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute–Working Group 1996 guidelines

Michael Hallek, Bruce D. Cheson, Daniel Catovsky et al. · Blood · 2008 · 3.2K citations · Full text

, , +14

Addition of rituximab to fludarabine and cyclophosphamide in patients with chronic lymphocytic leukaemia: a randomised, open-label, phase 3 trial

Michael Hallek, Kirsten Fischer, Guenter Fingerle-Rowson et al. · The Lancet · 2010 · 1.9K citations

, , +10

Long-term results of the fludarabine, cyclophosphamide, and rituximab regimen as initial therapy of chronic lymphocytic leukemia

Constantine S. Tam, Susan O’Brien, William G. Wierda et al. · Blood · 2008 · 689 citations · Full text

, , +16

Assessment of fludarabine plus cyclophosphamide for patients with chronic lymphocytic leukaemia (the LRF CLL4 Trial): a randomised controlled trial

Daniel Catovsky, Estella Matutes, R. F. Bezares et al. · The Lancet · 2007 · 679 citations

, , +13

Assessment of fludarabine plus cyclophosphamide for patients with chronic lymphocytic leukaemia (the LRF CLL4 Trial): a randomised controlled trial

Patrick J. Loehrer · Yearbook of Oncology · 2008 · 602 citations

, , +13